Skip to main content

MoneyWorks4Me

Piramal Pharma informs about disclosure

01 Apr 2023 Evaluate
Piramal Pharma has informed that it enclosed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA Inspection at Digwal facility.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..